| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.03 |